Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Orthocell Ltd ( (AU:OCC) ) is now available.
Orthocell Ltd has announced the issuance of 1,500,000 ordinary fully paid securities, which will be quoted on the Australian Securities Exchange (ASX) under the code OCC. This move is part of the company’s strategic efforts to enhance its capital structure, potentially strengthening its market position and providing additional resources for its ongoing projects in regenerative medicine.
The most recent analyst rating on (AU:OCC) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on Orthocell Ltd stock, see the AU:OCC Stock Forecast page.
More about Orthocell Ltd
Orthocell Ltd operates in the biotechnology industry, focusing on regenerative medicine. The company specializes in developing and commercializing products for the repair and regeneration of soft tissue injuries, with a market focus on improving patient outcomes in musculoskeletal conditions.
Average Trading Volume: 613,710
Technical Sentiment Signal: Buy
Current Market Cap: A$292.5M
For detailed information about OCC stock, go to TipRanks’ Stock Analysis page.